Science & Enterprise subscription

Please share Science & Enterprise

RSS
Follow by Email
Facebook
Facebook
Google+
Twitter
Visit Us
LinkedIn

Donate to our blog

Your support will help Science & Enterprise continue to provide science news for business people and business news for scientists.

Biotechs License Solid Tumor Therapy in $2.1B Deal

Biotechnology enterprise Immunomedics Inc. is licensing its enhanced antibody-based treatment for solid tumor cancers to Seattle Genetics, a developer of similar cancer drugs. . . . → Read More: Biotechs License Solid Tumor Therapy in $2.1B Deal

Gates Grant Funding Malaria Control Test Products

Two universities in the U.K. are developing testing protocols for a new generation of technologies coming to market to prevent mosquitoes from spreading diseases. . . . → Read More: Gates Grant Funding Malaria Control Test Products

Company, NC State Partner on Tissue Oxygen Patch

Profusa Inc. and a research center at North Carolina State University are developing a new device to monitor tissue oxygen levels in people with peripheral artery disease. . . . → Read More: Company, NC State Partner on Tissue Oxygen Patch

Companies Recognized for Patient Safety Innovations

Three companies received awards for their products aimed at reducing the number of preventable deaths occurring in American hospitals. . . . → Read More: Companies Recognized for Patient Safety Innovations

Protein Drug Discovery Company Launches, Gains $50M

A biotechnology enterprise founded by faculty at Scripps Research Institute plans to discover new therapies based on complex interactions with human proteins. . . . → Read More: Protein Drug Discovery Company Launches, Gains $50M

EU Project to Develop More Versatile Heart Pacemakers

An initiative in Europe plans to design a new type of pacemaker device that adapts to a host of signals in the cardiovascular system and regulates multiple heart functions. . . . → Read More: EU Project to Develop More Versatile Heart Pacemakers

Immunotherapy Biotech Raises $102 Million in IPO

A biotechnology company developing treatments for solid tumors, harnessing the body’s immune system, for cancer patients most likely to respond is raising $102 million in its initial public stock offering. . . . → Read More: Immunotherapy Biotech Raises $102 Million in IPO

Allergy Immunotherapy Firm Raises $2M in Early Funds

A biotechnology company in Finland developing an allergy vaccine that harnesses the immune system is raising €1.85 million ($US 2 million) in its first venture funding round. . . . → Read More: Allergy Immunotherapy Firm Raises $2M in Early Funds

Lilly Acquires Migraine Therapy Company in $960M Deal

Drug maker Eli Lilly and Company is acquiring CoLucid Pharmaceuticals, a developer of treatments for migraine pain and associated symptoms. . . . → Read More: Lilly Acquires Migraine Therapy Company in $960M Deal

California Set to Pioneer Blockchain ATMs in MMJ Dispensaries Statewide

California will see a new form of blockchain cryptocurrency POS terminals in key medical marijuana dispensaries around the state. . . . → Read More: California Set to Pioneer Blockchain ATMs in MMJ Dispensaries Statewide